About Dr Tirzepatide — Independent Editorial Publisher
About this site
Dr Tirzepatide is an independent editorial project that publishes summaries of the peer-reviewed research literature on tirzepatide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The domain modifier 'Dr' is editorial framing — a position this publisher occupies relative to the literature, reflecting a precise and document-first reading of the clinical record. It is not a claim that this site is operated by a physician, a pharmacy, or any licensed healthcare provider. We are explicit about this distinction.
Every quantitative claim on this site is cited to its source in the peer-reviewed literature. When the evidence is strong, we say so. When it is uncertain or preliminary, we note that. The editorial standard is accuracy and completeness — not optimism and not alarm.
This site documents the tirzepatide trial record: the SURMOUNT programme (obesity), the SURPASS programme (type 2 diabetes), SUMMIT (heart failure with preserved ejection fraction), SURMOUNT-OSA (obstructive sleep apnea), and SYNERGY-NASH (metabolic liver disease). We cite the primary sources. We do not extrapolate beyond them.
Editorial approach
The summary methodology is straightforward: primary published sources (randomised controlled trials, peer-reviewed meta-analyses, FDA label documents, regulatory records, and pharmacovigilance analyses) are read, paraphrased, and cited. No unpublished data, no manufacturer white papers, no secondary press releases. Where the published record is incomplete or contested, the site notes the gap or the disagreement.
This site does not make treatment recommendations. It does not advise on individual dosing, purchasing, or sourcing. It does not diagnose any condition. The appropriate resource for clinical guidance is a licensed medical professional with access to an individual's full medical history.
The 'what people report' sections on the effects page present patient community accounts. These are clearly labeled as anecdotal — distinct from the controlled trial record — and are included because they represent a real dimension of the compound's real-world profile. We do not allow anecdotal accounts to function as clinical claims.
Contact
Editorial enquiries and citation corrections may be directed via the contact page. Citation corrections are taken seriously — if a numbered reference is in error, we will correct it promptly.